Skip to content
★ Sign in to follow
SP

SynAct Pharma UR Stock: price and insider trades · Sweden

ISIN SE0013409646SE·

SynAct Pharma UR: what insiders have been doing

Only a handful of insider records exist for SynAct Pharma UR, the last one from 18 March 2020, too few to describe a trend. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 18 March 2020
Declarations1 total
  • ●
    Board of Director, Chief Strategy Officer/ Styrelseledamot, CSOExecutives
    0FI-SE
    2,080,311 shares0AktieISIN SE0013409646FI:csv-80e9f0cbb01535cf9388

1 of 1 declaration

About SynAct Pharma UR

SynAct Pharma UR is a pharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases. It is listed on the Stockholm Stock Exchange (XSTO).

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations